Pediatric Splenectomy

The spleen contributes to immune responses against encapsulated bacteria, so removing it changes how the child handles these organisms. This altered protection makes infection-prevention planning an essential part of care rather than a short-term surgical concern. Immunization and coordinated follow-up help clinicians address the long-term infectious risks created by the loss of splenic function.

Because the spleen filters blood, its removal can change how blood cells are managed after surgery. This is particularly relevant when the original disorder involves abnormal blood-cell handling or excessive splenic activity, such as hereditary spherocytosis or hypersplenism. Hematologic monitoring therefore remains important after the operation so clinicians can follow blood-related changes over time.

Pediatric splenectomy may be performed through open or laparoscopic access, with the approach selected according to the clinical situation and operative objective. The operation may focus on controlling bleeding after injury or removing abnormal splenic tissue. These access options allow surgeons to address different presentations while adapting the procedure to the child’s disease or trauma.

Preparation includes immunization and an infection-prevention plan established before surgery when possible. These measures address the spleen’s role in immune defense and anticipate the child’s changed infection risk after removal. Preoperative planning should also connect the surgical team with the clinicians responsible for later hematologic monitoring and long-term follow-up.

Postoperative care combines infection prevention with hematologic monitoring. Clinicians follow the child’s blood-related status because removing the spleen changes blood filtering and management, while prevention planning addresses reduced protection against encapsulated bacteria. Continued coordination is important because the consequences of splenic removal extend beyond the immediate recovery period and require ongoing attention.

The decision is reserved for selected situations in which splenic disease or injury threatens health and preserving the spleen is not feasible. Examples include hereditary spherocytosis, immune thrombocytopenia, severe splenic trauma, and hypersplenism. These conditions differ in cause, but each may create a clinical need to balance the original problem against the consequences of removing splenic function.